SCHEMBL21465896

SCHEMBL21465896

CC(C)N[C@@H](CNC(=O)OCCN=[N+]=[N-])C(=O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22314737 0.84 ACHE (0.35) —
SCHEMBL21465897 0.78 EPHX1 (0.32) —
SCHEMBL26759985 0.74 — —
SCHEMBL26192652 0.74 — —
SCHEMBL26759929 0.73 MEN1 (0.35) —
SCHEMBL23080162 0.72 ACHE (0.34) —
SCHEMBL20980231 0.72 ADRB2 (0.32) —
SCHEMBL15469229 0.71 GFPT1 (0.38) —
SCHEMBL29500239 0.69 ALDH1A1 (0.32) —
SCHEMBL26759934 0.69 ADRB2 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10442789-B2 Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use SUTRO BIOPHARMA, INC. (US) 2019-10-15 — — US disclosed
Send feedback